carbamates and sc 52151

carbamates has been researched along with sc 52151 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alam, M; Bechtold, CM; Colonno, RJ; Gong, YF; Greytok, JA; Lin, PF; Robinson, BS; Rose, RE; Terry, BJ1
Bold, G; Capraro, HG; Goutte, G; Klimkait, T; Lazdins, JK; Mestan, J; Walker, MR1

Other Studies

2 other study(ies) available for carbamates and sc 52151

ArticleYear
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Feb-20, Volume: 93, Issue:4

    Topics: Amino Acid Sequence; Carbamates; Clone Cells; DNA Mutational Analysis; DNA, Recombinant; DNA, Viral; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethanolamines; HeLa Cells; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Methylurea Compounds; Molecular Sequence Data; Point Mutation; Proviruses; Pyridines; Quinolines; Reassortant Viruses; Recombinant Fusion Proteins; Saquinavir; T-Lymphocytes; Urea; Valine

1996
In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitors.
    The Journal of infectious diseases, 1997, Volume: 175, Issue:5

    Topics: Anti-HIV Agents; Carbamates; Cell Line; Cells, Cultured; Ethylenes; Furans; HIV Protease Inhibitors; HIV Seronegativity; HIV-1; Humans; Indinavir; Kinetics; Lymphocytes; Orosomucoid; Ritonavir; Saquinavir; Sulfonamides; Urea; Virus Replication

1997